References
- Guay, DR. Review of cefditoren, an advanced-genera-tion, broad-spectrum oral cephalosporin. Clin Ther 2001; 23: 1924–37.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; eleventh informational supplement. M100-S11. NCCLS. Wayne, PA, 2001.
- Bassetti M, Manno G, Collida A, et al. Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis 2000; 6: 180–3.
- Cocuzza C, Blandino G, Mattina R, Nicoletti F, Nicoletti G. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania. Microb Drug Resist 1997; 3: 379–84.
- Savoia D, Avanzini C, Bosio K, et al. Macrolide resis-tance in group A streptococci. J Antimicrob Chemother 2000; 45: 41–7.
- Melo-Cristino J, Fernandes ML. Streptococcus pyo-genes isolated in Portugal: macrolide resistance, phenotypes and correlation with T types. Portuguese surveillance group for the study of respiratory pathogens. Microb Drug Resist 1999; 5: 219–25.
- Syrogiannopoulos GA, Grivea IN, Fitoussi F, et al. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatr Infect Dis J 2001; 20: 863–8.
- Perez-Trallero E, Fernández-Mazarrasa C, Garcia-Rey C, et al. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother 2001; 45: 3334–40.
- Granizo JJ, Aguilar L, Casal J, Dal-Re R, Bawer° F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother 2000; 46: 959–64.
- Giovanetti E, Prenna M, Repetto A, Biavasco F, Romagnoli M, Ripa S. Susceptibility of Streptococcus pyo-genes from throat cultures to macrolide antibiotics and influ-ence of collection criteria. Clin Microbiol Infect 1997; 3: 58–62.